Zobrazeno 1 - 10
of 591
pro vyhledávání: '"Geert R D'Haens"'
Autor:
Shaji Sebastian, Laurent Peyrin-Biroulet, Silvio Danese, Séverine Vermeire, Simon Travis, Jean-Frederic Colombel, Brian G Feagan, Vipul Jairath, Guangyong Zou, Geert R D’Haens, William J Sandborn, Gordon W Moran, Christopher Ma, Peter Bossuyt, Daniel Green, Mark S Silverberg, Maria Kłopocka, Marek Horynski, Stefanie C McFarlane, Zhongya Wang, Shashi Adsul, Marcelo Freire, Gabriela Radulescu, Julie Sigler, Jurij Hanžel, Rocio Sedano, Naveen Arya, Melanie Beaton, William Harlan, Rima Petroniene, Lukasz Wolanski
Publikováno v:
BMJ Open Gastroenterology, Vol 11, Iss 1 (2024)
Introduction Symptoms, endoscopy and histology have been proposed as therapeutic targets in ulcerative colitis (UC). Observational studies suggest that the achievement of histologic remission may be associated with a lower risk of complications, comp
Externí odkaz:
https://doaj.org/article/90b48a3e247b434da3279f2d6dcef059
Autor:
Andrew Y F Li Yim, Jessica R de Bruyn, Nicolette W Duijvis, Catriona Sharp, Enrico Ferrero, Wouter J de Jonge, Manon E Wildenberg, Marcel M A M Mannens, Christianne J Buskens, Geert R D'Haens, Peter Henneman, Anje A Te Velde
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0209656 (2018)
BackgroundThe chronic remitting and relapsing intestinal inflammation characteristic of Crohn's disease frequently leads to fibrosis and subsequent stenosis of the inflamed region. Approximately a third of all Crohn's disease patients require resecti
Externí odkaz:
https://doaj.org/article/4d247c38076e4a7984fa3ae11f10c912
Autor:
Jessica R de Bruyn, Marte A Becker, Jessica Steenkamer, Manon E Wildenberg, Sybren L Meijer, Christianne J Buskens, Willem A Bemelman, Mark Löwenberg, Cyriel Y Ponsioen, Gijs R van den Brink, Geert R D'Haens
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0190999 (2018)
Overt fibrostenotic disease is a relative contraindication for anti-TNF therapy in Crohn's disease. We hypothesized that subclinical fibrosis may also contribute to an incomplete response to anti-TNF therapy before the onset of symptomatic stenosis.I
Externí odkaz:
https://doaj.org/article/a23a1cc59d27494d855c8b82973cb9d8
Autor:
Lianne Heuthorst, Houda Harbech, Harmanna J. Snijder, Aart Mookhoek, Geert R. D'Haens, Séverine Vermeire, André D'Hoore, Willem A. Bemelman, Christianne J. Buskens
Publikováno v:
American Journal of Gastroenterology. 118:848-854
INTRODUCTION: The aim of the current study was to assess whether there is an indication shift for surgery in patients with ulcerative colitis (UC) from refractory disease to malignant degeneration over the past 3 decades. METHODS: All patients with h
Autor:
Jurij Hanžel, Vipul Jairath, Christopher Ma, Leonardo Guizzetti, Guangyong Zou, Cynthia S. Santillan, Stuart A. Taylor, Tanja van Viegen, Geert R. D’Haens, Brian G. Feagan, Julián Panés, Jordi Rimola
Publikováno v:
Clinical gastroenterology and hepatology, 20(11), 2598-2606. W.B. Saunders Ltd
Background & Aims: Magnetic resonance enterography (MRE) is having an increasing role in Crohn's disease; however, fully validated indices are needed. We evaluated the responsiveness of 4 MRE indices in luminal Crohn's disease. Methods: Paired MRE im
Autor:
Geert R. D’Haens, William J. Sandborn
Publikováno v:
Gastroenterology, 164(1), 166-168. W.B. Saunders Ltd
Autor:
Elise M Meima-van Praag, Kyra L van Rijn, Karin A T G M Wasmann, Harmanna J Snijder, Jaap Stoker, Geert R D'Haens, Krisztina B Gecse, Michael F Gerhards, Jeroen M Jansen, Marcel G W Dijkgraaf, Jarmila D W van der Bilt, Marco W Mundt, Antonino Spinelli, Silvio Danese, Willem A Bemelman, Christianne J Buskens
Publikováno v:
The Lancet Gastroenterology and Hepatology, 7(7), 617-626. Elsevier Ltd
Meima-van Praag, E M, van Rijn, K L, Wasmann, K A T G M, Snijder, H J, Stoker, J, D'Haens, G R, Gecse, K B, Gerhards, M F, Jansen, J M, Dijkgraaf, M G W, van der Bilt, J D W, Mundt, M W, Spinelli, A, Danese, S, Bemelman, W A & Buskens, C J 2022, ' Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II) : a patient preference randomised trial ', The Lancet Gastroenterology and Hepatology, vol. 7, no. 7, pp. 617-626 . https://doi.org/10.1016/S2468-1253(22)00088-7
Meima-van Praag, E M, van Rijn, K L, Wasmann, K A T G M, Snijder, H J, Stoker, J, D'Haens, G R, Gecse, K B, Gerhards, M F, Jansen, J M, Dijkgraaf, M G W, van der Bilt, J D W, Mundt, M W, Spinelli, A, Danese, S, Bemelman, W A & Buskens, C J 2022, ' Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II) : a patient preference randomised trial ', The Lancet Gastroenterology and Hepatology, vol. 7, no. 7, pp. 617-626 . https://doi.org/10.1016/S2468-1253(22)00088-7
Background: Guidelines on Crohn's perianal fistulas recommend anti-tumour necrosis factor (TNF) treatment and suggest considering surgical closure for patients with surgically amenable disease. However, long-term outcomes following these two strategi
Autor:
Julián Panés, Jean-Frederic Colombel, Geert R. D’Haens, Stefan Schreiber, Remo Panaccione, Laurent Peyrin-Biroulet, Edward V. Loftus, Silvio Danese, Satoshi Tanida, Yusuke Okuyama, Edouard Louis, Alessandro Armuzzi, Marc Ferrante, Harald Vogelsang, Toshifumi Hibi, Mamoru Watanabe, Jessica Lefebvre, Tricia Finney-Hayward, Yuri Sanchez Gonzalez, Thao T. Doan, Nael M. Mostafa, Kimitoshi Ikeda, Wangang Xie, Bidan Huang, Joel Petersson, Jasmina Kalabic, Anne M. Robinson, William J. Sandborn
Publikováno v:
Gastroenterology, 162(7), 1891-1910. W.B. Saunders Ltd
BACKGROUND & AIMS: SERENE UC (Study of a Novel Approach to Induction and Maintenance Dosing With Adalimumab in Patients With Moderate to Severe Ulcerative Colitis) evaluated the efficacy of higher adalimumab induction and maintenance dose regimens in
Publikováno v:
Gastroenterology. 164:1347-1348
Autor:
Geert R. D'Haens, Florian Rieder, Rocio Sedano, Tran M Nguyen, Ahmed Almradi, Claire E Parker, Brian G. Feagan, Christopher Ma, Lisa M. Shackelton, William J. Sandborn, Vipul Jairath
Publikováno v:
Inflamm Bowel Dis
Background Several indices exist to measure pouchitis disease activity; however, none are fully validated. As an initial step toward creating a validated instrument, we identified pouchitis disease activity indices, examined their operating propertie